- Home
- / Guanhao Biotech
Guanhao Biotech
Stock Price
¥13.2
2023-08-30
Market Capitalization
¥3.5 B
2023-08-30
Revenue
¥356.8 M
FY, 2022
Guanhao Biotech Summary
Company Summary
- Overview
- Guanhao Biotech (冠昊生物科技股份有限公司) is a company that researches, develops, produces, and sells regeneration medical materials and implanted devices. It provides biological dura mater patches, chest general surgery department patching membranes, intraocular lens, asepsis biological wound, etc.
- Type
- Public
- Status
- Active
- HQ
- Guangzhou, CN | view all locations
- Website
- http://www.grandhopebio.com
Table of Contents
LocationsView all
3 locations detected
Guangzhou, Guang Dong Sheng HQ
China
No. 12, Yuyan Road
Beijing, Bei Jing Shi
China
18th Floor, Guoxing Building, No. 22, Capital Gymnasium South Road
Guangzhou, Guang Dong Sheng
China
Room 3805A, 38th Floor, R&F Yingkai Plaza, No. 16, Huaxia Road
Guanhao Biotech Financials
Summary Financials
- Revenue (Q1, 2023)
- ¥111.7M
- Gross profit (Q1, 2023)
- ¥86.1M
- Net income (Q1, 2023)
- ¥24.1M
- Cash (Q1, 2023)
- ¥127.3M
- EBIT (Q1, 2023)
- ¥28.4M
- Enterprise value
- $3.5B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2023